Navigating the Prognostic Complexity of <scp>IgH</scp> Cytogenetic Abnormalities in Multiple Myeloma Among Diverse <scp>IgH</scp> Cytogenetic Abnormalities–Involved High‐Risk Stratifications
IgH cytogenetic abnormalities indicate aggressive disease and poorer survival in NDMM, especially when accompanied by other high-risk markers. ASCT may mitigate these adverse outcomes, supporting its role in individualized treatment strategies.
Authors
- Dong Tian (ORCID: https://orcid.org/0000-0001-8510-8309)
- Ling Pan
- Wenjiao Tang (ORCID: https://orcid.org/0000-0001-5576-1788)
- Li Zhang (ORCID: https://orcid.org/0009-0004-8547-1326)
- Ting Niu (ORCID: https://orcid.org/0000-0003-1580-1014)
- Bing Xiang (ORCID: https://orcid.org/0000-0001-6534-7476)
- Meng Li (ORCID: https://orcid.org/0000-0001-8502-7621)
- Yan Li (ORCID: https://orcid.org/0000-0001-9078-5101)
- Yanqiu Xiong
Institutions
- Chengdu Medical College (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Chengdu University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1002/cam4.71152
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00